Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 327.47%101.32M | -57.43%38.1M | -42.19%23.7M | 120.13%89.5M | 48.37%41M | 843.80%40.66M | 1,149.10%27.63M | -69.46%4.31M | -63.56%2.21M | 160.32%14.11M |
| Operating income | 327.47%101.32M | -57.43%38.1M | -42.19%23.7M | 120.13%89.5M | 48.37%41M | 843.80%40.66M | 1,149.10%27.63M | -69.46%4.31M | -63.56%2.21M | 160.32%14.11M |
| Cost of sales | -309.70%-4.86M | -120.55%-4.49M | -5,052.17%-1.19M | -1,464.62%-2.03M | 66.18%-23K | 5.11%-130K | ---68K | 69.49%-137K | ---- | 27.93%-449K |
| Operating expenses | -309.70%-4.86M | -120.55%-4.49M | -5,052.17%-1.19M | -1,464.62%-2.03M | 66.18%-23K | 5.11%-130K | -68K | 69.49%-137K | 27.93%-449K | |
| Gross profit | 328.41%96.46M | -61.57%33.61M | -45.05%22.52M | 115.82%87.47M | 48.66%40.97M | 871.69%40.53M | 1,146.02%27.56M | -69.46%4.17M | -61.75%2.21M | 184.78%13.66M |
| Selling expenses | -67.99%-2.87M | -152.07%-2.68M | ---1.71M | ---1.06M | ---- | ---- | ---- | ---- | ---- | ---- |
| Administrative expenses | 7.04%-7.36M | 32.45%-13.17M | 7.68%-7.92M | 28.51%-19.5M | 44.09%-8.58M | 31.93%-27.27M | 39.29%-15.34M | 13.45%-40.07M | -376.22%-25.27M | -337.27%-46.29M |
| Research and development expenses | -37.13%-17.96M | 53.42%-21M | 53.86%-13.1M | 66.64%-45.08M | 66.06%-28.38M | -26.18%-135.14M | -103.04%-83.62M | -93.87%-107.1M | -170.98%-41.18M | -11.66%-55.24M |
| Revaluation surplus | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -1,496.35%-213.7M |
| -Changes in the fair value of other assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -1,496.35%-213.7M |
| Impairment and provision | ---25K | 8.15%-462K | ---- | ---503K | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other impairment is provision | ---25K | 8.15%-462K | ---- | ---503K | ---- | ---- | ---- | ---- | ---- | ---- |
| Special items of operating profit | 75.66%6.13M | 109.16%10.94M | 183.35%3.49M | 139.79%5.23M | 239.89%1.23M | -345.88%-13.15M | -132.82%-880K | 2.32%5.35M | 943.08%2.68M | 308.20%5.23M |
| Operating profit | 2,165.43%74.37M | -72.72%7.24M | -37.47%3.28M | 119.66%26.55M | 107.26%5.25M | 1.90%-135.03M | -17.41%-72.28M | 53.55%-137.65M | -27.71%-61.56M | -339.86%-296.36M |
| Financing cost | 48.24%-807K | 9.48%-3.51M | 33.57%-1.56M | -94.87%-3.87M | -308.89%-2.35M | -1,028.98%-1.99M | -1,371.79%-574K | 37.14%-176K | 83.40%-39K | -31.46%-280K |
| Earning before tax | 4,167.23%73.57M | -83.52%3.74M | -40.61%1.72M | 116.55%22.68M | 103.98%2.9M | 0.59%-137.02M | -18.27%-72.85M | 53.54%-137.83M | -27.17%-61.6M | -338.89%-296.64M |
| Tax | -73.70%-568K | -1,330.86%-997K | -3,072.73%-327K | 132.66%81K | 104.80%11K | -406.12%-248K | -1,172.22%-229K | -149.49%-49K | -133.33%-18K | 7.61%99K |
| After-tax profit from continuing operations | 5,125.41%73M | -87.95%2.74M | -52.06%1.4M | 116.58%22.76M | 103.99%2.91M | 0.44%-137.27M | -18.61%-73.08M | 53.50%-137.88M | -27.35%-61.62M | -339.34%-296.54M |
| Earning after tax | 5,125.41%73M | -87.95%2.74M | -52.06%1.4M | 116.58%22.76M | 103.99%2.91M | 0.44%-137.27M | -18.61%-73.08M | 53.50%-137.88M | -27.35%-61.62M | -339.34%-296.54M |
| Minority profit | 4,844.44%1.28M | -5.88%-36K | -237.50%-27K | 26.09%-34K | 71.43%-8K | 54.46%-46K | 49.09%-28K | 28.87%-101K | 28.57%-55K | -294.44%-142K |
| Profit attributable to shareholders | 4,936.38%71.72M | -87.81%2.78M | -51.27%1.42M | 116.61%22.8M | 104.00%2.92M | 0.40%-137.22M | -18.67%-73.05M | 53.52%-137.78M | -27.44%-61.56M | -339.37%-296.4M |
| Basic earnings per share | 0.09 | 0 | 0 | 115.79%0.03 | 0 | 0.00%-0.19 | -25.00%-0.1 | 88.76%-0.19 | 79.49%-0.08 | -196.49%-1.69 |
| Diluted earnings per share | 0.09 | 0 | 0 | 115.79%0.03 | 0 | 0.00%-0.19 | -25.00%-0.1 | 88.76%-0.19 | 79.49%-0.08 | -196.49%-1.69 |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young Accounting Firm | -- | Ernst & Young Accounting Firm | -- | Ernst & Young Accounting Firm |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.